Versant Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.72M | Buy |
|
|||||
|
2025
Q2 | $1.01M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $486K | Buy |
|
|||||
|
2024
Q3 | $403K | Buy |
|
|||||
|
2024
Q2 | $245K | Sell |
|
|||||
|
2024
Q1 | $279K | Sell |
|
|||||
|
2023
Q4 | $345K | Sell |
|
|||||
|
2023
Q3 | $334K | Buy |
|
|||||
|
2023
Q2 | $298K | Sell |
|
|||||
|
2023
Q1 | $354K | Buy |
|
|||||
|
2022
Q4 | $349K | Buy |
|
|||||
|
2022
Q3 | $289K | Buy |
|
|||||
|
2022
Q2 | $322K | Buy |
|
|||||
|
2022
Q1 | $341K | Buy |
|
|||||
|
2021
Q4 | $284K | Buy |
|
|||||
|
2021
Q3 | $213K | Buy |
|
|||||
|
2021
Q2 | $197K | Buy |
|
|||||
|
2021
Q1 | $186K | Buy |
|
|||||
|
2020
Q4 | $128K | Sell |
|
|||||
|
2020
Q3 | $272K | Buy |
|
|||||
|
2020
Q2 | $304K | Buy |
|
|||||
|
2020
Q1 | $233K | Buy |
|
|||||
|
2019
Q4 | $258K | Sell |
|
|||||
|
2019
Q3 | $223K | Sell |
|
|||||
|
2019
Q2 | $228K | Sell |
|
|||||
|
2019
Q1 | $278K | Sell |
|
|||||
|
2018
Q4 | $353K | Hold |
|
|||||
|
2018
Q3 | $362K | Sell |
|
|||||
|
2018
Q2 | $362K | Sell |
|
|||||
|
2018
Q1 | $372K | Sell |
|
|||||
|
2017
Q4 | $394K | Buy |
|
|||||
|
2017
Q3 | $335K | Hold |
|
|||||
|
2017
Q2 | $273K | Buy |
|
|||||
|
2017
Q1 | $245K | Hold |
|
|||||
|
2016
Q4 | $235K | Sell |
|
|||||
|
2016
Q3 | $238K | Sell |
|
|||||
|
2016
Q2 | $235K | Sell |
|
|||||
|
2016
Q1 | $219K | Sell |
|
|||||
|
2015
Q4 | $229K | Buy |
|